Next Article in Journal
Influence of Speciation of Thorium on Toxic Effects to Green Algae Chlorella pyrenoidosa
Next Article in Special Issue
Moringa Leaves Prevent Hepatic Lipid Accumulation and Inflammation in Guinea Pigs by Reducing the Expression of Genes Involved in Lipid Metabolism
Previous Article in Journal
Lysozyme Associated Liposomal Gentamicin Inhibits Bacterial Biofilm
Previous Article in Special Issue
Recent Advances in Nanoparticle-Mediated Delivery of Anti-Inflammatory Phytocompounds
Open AccessArticle

Ginkgolide A Ameliorates LPS-Induced Inflammatory Responses In Vitro and In Vivo

Institute of Genetics and Cytology, Northeast Normal University, Changchun 130024, China
National Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun 130024, China
Authors to whom correspondence should be addressed.
Academic Editors: Paula Andrade and Patrícia Valentão
Int. J. Mol. Sci. 2017, 18(4), 794;
Received: 8 March 2017 / Revised: 31 March 2017 / Accepted: 6 April 2017 / Published: 10 April 2017
(This article belongs to the Special Issue Natural Anti-Inflammatory Agents)
Ginkgolide A (GA) is a natural compound isolated from Ginkgo biloba and has been used to treat cardiovascular diseases and diabetic vascular complications. However, only a few studies have been conducted on the anti-inflammatory effects of GA. In particular, no related reports have been published in a common inflammation model of lipopolysaccharide (LPS)-stimulated macrophages, and the anti-inflammatory mechanisms of GA have not been fully elucidated. In the present study, we extensively investigated the anti-inflammatory potential of GA in vitro and in vivo. We showed that GA could suppress the expression of pro-inflammatory mediators (cyclooxygenase-2 (COX-2) and nitric oxide (NO) and pro-inflammatory cytokines (tumor necrosis factor (TNF)-α, interleukin (IL)-6 and IL-1β) in LPS-treated mouse peritoneal macrophages, mouse macrophage RAW264.7 cells, and differentiated human monocytes (dTHP-1) in vitro. These effects were partially carried out via downregulating Nuclear factor kappa-B (NF-κB), Mitogen-activated protein kinases (MAPKs) (p38 mitogen-activated protein kinase and extracellular signal-regulated kinase (ERK), but not c-Jun N-terminal kinase (JNK), and activating the AMP-activated protein kinase (AMPK) signaling pathway also seems to be important. Consistently, GA was also shown to inhibit the LPS-stimulated release of TNF-α and IL-6 in mice. Taken together, these findings suggest that GA can serve as an effective inflammatory inhibitor in vitro and in vivo. View Full-Text
Keywords: Ginkgolide A; inflammation; AMPK; NF-κB; MAPKs Ginkgolide A; inflammation; AMPK; NF-κB; MAPKs
Show Figures

Graphical abstract

MDPI and ACS Style

Li, Y.; Wu, Y.; Yao, X.; Hao, F.; Yu, C.; Bao, Y.; Wu, Y.; Song, Z.; Sun, Y.; Zheng, L.; Wang, G.; Huang, Y.; Sun, L.; Li, Y. Ginkgolide A Ameliorates LPS-Induced Inflammatory Responses In Vitro and In Vivo. Int. J. Mol. Sci. 2017, 18, 794.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map

Back to TopTop